检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张伟[1] 涂频[1] 王建军[1] 何燕[1] 余波[1] 王海[1] 石群立[1]
机构地区:[1]南京大学医学院临床学院/南京军区南京总医院病理科,江苏南京210002
出 处:《中华男科学杂志》2015年第2期157-160,共4页National Journal of Andrology
摘 要:目的:探讨附睾乳头状囊腺瘤的临床病理学特征。方法:应用常规病理、免疫组化方法观察2例附睾乳头状囊腺瘤手术切除标本,结合相关临床资料及其病理学特点进行分析,并复习相关文献。结果:2例患者均为成年男性。临床表现为阴囊(附睾处)无痛性肿块,或偶有隐痛及下坠感。肿瘤组织学包括3个主要特征:扩张的导管和小囊肿及被覆高柱状上皮、以纤维血管间质为轴心的乳头状增生的腺样结构,囊腔内可见嗜酸性物质。免疫表型:瘤细胞表达CK8/18、CK7、EMA;而CK20、CEA、MC、Calretinin、P53、P63、SMA、VHL和CD10均阴性,Ki67<1%阳性。随访:2例患者预后良好。结论:附睾乳头状囊腺瘤是泌尿生殖系统少见的良性肿瘤,可伴有VHL综合征。手术是治疗该肿瘤的首选方法。Objective : To study the clinicopathological characteristics of papillary cystadenoma of the epididymis. Methods : Using routine pathology and immunohistochemistry, we observed the surgically obtained samples from 2 cases of papillary cystadenoma of the epididymis, analyzed their pathological features and clinical presentations, and reviewed the related literature. Results: The 2 patients were both adult males. The tumors typically manifested as painless swelling in the epididymis, with occasionally dull pain and tenesmus in 1 of the cases. Pathologically, the lesions exhibited three morphological features, i. e. , dilated ducts and small cysts sur- rounded by fibrous connective tissue, adenoid papillary hyperplasia into the cysts embraced by fibrovascular stroma, and acidophil sub- stance present in the cysts. Immunohistochemistry showed that the tumors were strongly positive for CK8/18, CKT, and EMA, but neg- ative for CK20, CEA, MC, Calretenin, P53, P63, SMA, VHL, and CD10, with the positive rate of Ki-67 〈 1%. Follow-up visits revealed good prognosis in both cases. Conclusion : Papillary cystadenoma of the epididymis is a rare benign tumor in the male urogeni- tal system, which may be accompanied by the VHL syndrome. Surgery is the first choice for its treatment.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145